|
2024
|
Invention
|
Catalytic copolymer composition.
A catalytic composition comprising a transition metal catalyst ... |
|
|
Invention
|
Polymorphic forms of savolitinib. The present disclosure relates to novel co-crystals of savoliti... |
|
2023
|
Invention
|
Process for the preparation of lisdexamfetamine. An efficient, economical and continuous process ... |
|
|
Invention
|
Processes for the preparation and manufacture of relugolix. Intermediates and processes for the p... |
|
|
Invention
|
Bexagliflozin in monohydrate, dihydrate or amorphous forms. The present invention discloses polym... |
|
|
Invention
|
Polymorphs, co-crystals and solvates of fruquintinib, processes for the preparation and use there... |
|
2022
|
Invention
|
Process for preparing brivaracetam. The present invention is directed to a novel compound, (4R)-1... |
|
|
Invention
|
Processes for preparing tucatinib polymorphs.
The present invention is directed to processes for... |
|
|
Invention
|
Novel forms of entinostat.
The present disclosure relates to various crystalline forms of entino... |
|
|
Invention
|
Novel forms of entinostat. The present disclosure relates to various crystalline forms of entinos... |
|
2021
|
Invention
|
Processes for making a solid-state form of relugolix. The present invention is directed to proces... |
|
|
Invention
|
Crystalline product.
The present invention provides a molecular complex of binimetinib, which is... |
|
|
Invention
|
Process for preparing remifentanil hydrochloride. The present invention provides a process for pr... |
|
|
Invention
|
Novel forms of pracinostat dihydrochloride.
The present disclosure relates to various solid-stat... |
|
|
Invention
|
Niraparib solid state form. The present disclosure relates to a stabilized anhydrous p-toluenesul... |
|
|
Invention
|
Process for preparing trientine dihydrochloride.
The present invention relates to a process for ... |
|
|
Invention
|
Crystalline forms of voxelotor, and processes for the preparation thereof.
The present invention... |
|
|
Invention
|
Crystalline forms of voxelotor, and processes for the preparation thereof. The present applicatio... |
|
|
Invention
|
Novel form of bardoxolone methyl.
The present disclosure relates to a formic acid solvate of bar... |
|
2020
|
Invention
|
Form of ponatinib. The present disclosure relates to Form Z of acetic acid solvated hydrate of po... |
|
|
Invention
|
Crystalline forms of entrectinib.
The present invention relates to crystalline forms of entrecti... |
|
|
Invention
|
Forms of fedratinib dihydrochloride. The present disclosure relates to novel forms of fedratinib ... |
|
|
Invention
|
Polymorphs of avapritinib and methods for preparing the polymorphs.
The present invention relate... |
|
|
Invention
|
Polymorphs of avapritinib and methods for preparing the polymorphs. The present application relat... |
|
|
Invention
|
Crystalline forms of dasatinib. The present disclosure relates to a dasatinib co-crystal form com... |
|
|
Invention
|
Solid-state forms of abemaciclib, their use and preparation. The invention relates to a crystalli... |
|
|
Invention
|
Solid-state forms of regadenoson, their use and preparation. The invention relates to a crystalli... |
|
|
Invention
|
Pyridine or n,n-dimethyl acetamide solvated solid state forms of solvated idelalisib, their use a... |
|
|
Invention
|
Polymorph of venetoclax and method for preparing the polymorph.
The present invention relates to... |
|
|
Invention
|
Polymorph of venetoclax and method for preparing the polymorph. The present invention relates to ... |
|
|
Invention
|
Molecular complexes.
The present invention relates to a crystalline molecular complex comprising... |
|
|
Invention
|
Solid-state forms of relugolix.
The present invention is directed to a solid-state DMF solvate o... |
|
|
Invention
|
Solid-state forms of relugolix. The present invention is directed to a solid-state DMF solvate of... |
|
|
Invention
|
Process.
The present invention relates to additive layer manufacture methods for producing a cur... |
|
|
Invention
|
Amorphous umbralisib monotosylate.
The present disclosure is directed to amorphous umbralisib mo... |
|
|
Invention
|
Amorphous umbralisib monotosylate. The present disclosure is directed to amorphous umbralisib mon... |
|
|
Invention
|
Process. The present invention relates to additive layer manufacture methods for producing a cure... |
|
|
Invention
|
Co-crystal forms of selinexor. The present invention is directed to selinexor co-crystal forms; m... |
|
|
Invention
|
Process.
The present invention provides processes for the preparation of a hydrochloric acid sal... |
|
|
Invention
|
Crystalline solvate of binimitinib with dmso and cocrystalline form of binimitinib with citric ac... |
|
2019
|
Invention
|
Forms of afatinib dimaleate. The present disclosure is directed to a crystalline, hydrated form o... |
|
|
Invention
|
Forms of apremilast. The present disclosure is directed to novel forms of apremilast and pharmace... |
|
|
Invention
|
Processes for making opioids including 14-hydroxycodeinone and 14-hydroxymorphinone. Improved pro... |
|
2018
|
Invention
|
Hydrogenation process for preparing oxycodone hydrochloride from 14-hydroxycodeinone. A process f... |
|
2017
|
Invention
|
Process for preparing alkyl esters of 4-(5-(bis(2-hydroxyethyl)amino-1-methyl-1h-benzo[d]imidazol... |
|
|
Invention
|
Processes for making alkylated arylpiperazine and alkylated arylpiperidine compounds including no... |
|
|
G/S
|
Chemical preparations and substances used to denaturise other chemical substances by rendering th... |
|
2007
|
G/S
|
Chemical preparations and substances used to denature other chemical substances by rendering them... |
|
|
G/S
|
Chemical preparations and substances used to denaturise
other chemical substances by rendering t... |
|
|
G/S
|
Chemical preparations and other substances used to denature other chemical substances by renderin... |
|
|
G/S
|
Chemical compounds for use in the manufacture of pharmaceuticals; chemicals for use as active pha... |
|
|
G/S
|
Chemical compounds for use in the manufacture of
pharmaceuticals; active pharmaceutical intermed... |
|
2006
|
G/S
|
Chemical, pharmaceutical and scientific research for others; development for others of chemicals,... |
|
1996
|
G/S
|
promoting public safety awareness by means of contests and information concerning police, ambulan... |
|
1995
|
G/S
|
Chemicals for use in industry, agriculture, horticulture, silviculture and forestry, namely chemi... |
|
1990
|
G/S
|
unpleasant tasting flavoring for use as a denaturant in consumer products; namely, disinfectants ... |
|
1961
|
G/S
|
Chemical Substance for Use as a Denaturant for Alcohol |
|
1959
|
G/S
|
A chemical substance for use as a denaturant for alcohol.
Chemical preparations and substances us... |
